SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057805
Filing Date
2024-05-10
Accepted
2024-05-10 16:05:52
Documents
58
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cytk-20240331.htm   iXBRL 10-Q 2008147
2 EX-10.1 cytk-ex10_1.htm EX-10.1 40574
3 EX-10.2 cytk-ex10_2.htm EX-10.2 39125
4 EX-31.1 cytk-ex31_1.htm EX-31.1 14845
5 EX-31.2 cytk-ex31_2.htm EX-31.2 14930
6 EX-32.1 cytk-ex32_1.htm EX-32.1 8628
7 GRAPHIC img197571864_0.jpg GRAPHIC 7536
  Complete submission text file 0000950170-24-057805.txt   7724860

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20240331.xsd EX-101.SCH 1256156
61 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20240331_htm.xml XML 1064303
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50633 | Film No.: 24934798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)